Papüloskuamöz Hastalıklar
Özet
Papüloskuamöz hastalıklar, farklı klinik ve histopatolojik özellikler göstermekle birlikte benzer morfolojik bulgular nedeniyle tanısal güçlük oluşturabilen bir grup deri hastalığıdır. Bu bölümde psöriyazis, liken planus ve pitriyazis rozea; epidemiyoloji, etiyoloji, patogenez, klinik özellikler, histopatoloji, tanı, ayırıcı tanı, tedavi, seyir ve sevk kriterleri açısından ele alınmıştır. Psöriyazis, genetik yatkınlık ve çevresel tetikleyicilerin rol oynadığı, kronik ve tekrarlayıcı enflamatuar bir hastalıktır. Klinik görünümü ve şiddeti farklılık gösterebilir; topikal tedavilerden fototerapi, sistemik ve biyolojik tedavilere kadar geniş bir tedavi seçeneğine sahiptir. Liken planus, T hücre aracılı immünolojik mekanizmaların ön planda olduğu, deri, mukoza, saç ve tırnakları tutabilen kronik bir hastalıktır. Pitriyazis rozea ise çoğunlukla gençlerde görülen, kendini sınırlayan ve genellikle 6–8 hafta içinde spontan gerileyen bir papüloskuamöz dermatozdur. Her üç hastalıkta da doğru tanı için ayrıntılı klinik değerlendirme ve gerektiğinde histopatolojik inceleme önemlidir. Hastalığın yaygınlığı, şiddeti, özel bölge tutulumu ve eşlik eden hastalıklar tedavi ve dermatolojiye sevk kararını belirlemede temel unsurlardır.
Referanslar
Chakith MRS, Pradeep S, Gangadhar M, et al. Advancements in understanding and treating psoriasis: a comprehensive review of pathophysiology, diagnosis, and therapeutic approaches. PeerJ. 2025;13: e19325. doi: 10.7717/peerj.19325.
Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. International Journal of Molecular Sciences. 2019;20(6): 1475. doi: 10.3390/ijms20061475.
Armstrong AW, Blauvelt A, Callis Duffin K, et al. Psoriasis. Nat Rev Dis Primers. 2025;11(1): 45. doi: 10.1038/s41572-025-00630-5.
Plewig G, French L, Ruzicka T, et al. Braun-Falco Dermatoloji. (Engin B, Kartal SP, Koca R, vd., Çev. Ed.). İstanbul: Ema Tıp Kitabevi; 2024. p.673–696.
Lebwohl M. Psoriasis. Annals of Internal Medicine. 2018;168(7): 49–64. doi:10.7326/aitc201804030.
Dodge T. Guttate psoriasis: another kid with an itchy rash. Advanced Emergency Nursing Journal. 2025;47(3): 193–197. doi:10.1097/tme.0000000000000576.
Benjegerdes KE, Hyde K, Kivelevitch D, et al. Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis: Targets and Therapy. 2016;(6): 131–144. doi:10.2147/ptt.s98954.
Perez-Chada LM, Elman S, Villa-Ruiz C, et al. Psoriatic arthritis: a comprehensive review for the dermatologist part I: epidemiology, comorbidities, pathogenesis, and diagnosis. Journal of the American Academy of Dermatology. 2025;92(5): 969–982. doi: 10.1016/j.jaad.2024.03.058.
Balan R, Grigoraş A, Popovici D, et al. The histopathological landscape of the major psoriasiform dermatoses. Archives of Clinical Cases. 2021;6(3): 59–68. doi:10.22551/2019.24.0603.10155.
Chan JJ. Psoriasis: an update on topical and systemic therapies. Aust Prescr. 2025;48(3): 87-92. doi: 10.18773/austprescr.2025.026.
Ahmed SS, Manchanda Y, De A, Das S, Kumar R. Topical therapy in Psoriasis. Indian J Dermatol. 2023;68(4): 437-445. doi: 10.4103/ijd.ijd_422_23.
Torres T, Henrique M, Oliveira H. et al. Management of Psoriasis by Family Physicians: Referral Algorithm and Shared Management with Dermatology. Acta Med Port. 2021;34(10): 682-689. doi: 10.20344/amp.13159.
Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. The Scientific World Journal. 2014;2014: 742826. doi:10.1155/2014/742826.
Wollina U, Koch A, Fida M, et al. Lichen planus: the role of age and gender in clinical appearance and treatment. Wiener Medizinische Wochenschrift. 2025;175(13–14): 311–330. doi:10.1007/s10354-024-01057-5.
Le Cleach L, Chosidow O. Lichen planus. New England Journal of Medicine. 2012;366(8): 723–732. doi:10.1056/nejmcp1103641.
Kofoed ML, Wantzin GL. Familial lichen planus. More frequent than previously suggested? Journal of the American Academy of Dermatology. 1985;13(1): 50–54. doi:10.1016/S0190-9622(85)70142-9.
Tekin B, Xie F, Lehman JS. Lichen planus: what is new in diagnosis and treatment? American Journal of Clinical Dermatology. 2024;25(5): 735–764. doi:10.1007/s40257-024-00878-9.
Vičić M, Hlača N, Kaštelan M, et al. Comprehensive insight into lichen planus immunopathogenesis. International Journal of Molecular Sciences. 2023;24(3): 3038. doi:10.3390/ijms24033038.
Weston G, Payette M. Update on lichen planus and its clinical variants. International Journal of Women's Dermatology. 2015;1(3) :140–149. doi: 10.1016/j.ijwd.2015.04.001.
Glavina A, Zanze L, Barac E, et al. Oral lichen planus: key features of etiopathogenesis, diagnosis, and management. Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 2025;34(3): 109–115.
Svigos K, Yin L, Fried L, et al. A practical approach to the diagnosis and management of classic lichen planopilaris. American Journal of Clinical Dermatology. 2021;22(5): 681–692. doi:10.1007/s40257-021-00630-7.
Gupta MK, Lipner SR. Review of nail lichen planus: epidemiology, pathogenesis, diagnosis, and treatment. Dermatologic Clinics. 2021;39(2): 221–230. doi: 10.1016/j.det.2020.12.002.
Hosamane S, Pai M, Philipose TR, et al. Clinicopathological study of non-infectious erythaematous papulosquamous skin diseases. Journal of Clinical and Diagnostic Research. 2016;10(6): 19–22. doi:10.7860/jcdr/2016/18607.8029.
Litaiem N, Mansour Y, Jones M, et al. Dermoscopic signs of lichen planus. BMJ Case Reports. 2016;2016: bcr2015213923. doi:10.1136/bcr-2015-213923.
Promsena P, Iamsumang W, Rutnin S. Clinicopathological characteristics of lichenoid drug eruption: a 17-year retrospective study. Clinical, Cosmetic and Investigational Dermatology. 2025;18: 3203–3211. doi:10.2147/ccid.s560840.
Solimani F, Forchhammer S, Schloegl A, et al. Lichen planus: a clinical guide. Journal der Deutschen Dermatologischen Gesellschaft. 2021;19(6): 864–882. doi:10.1111/ddg.14565.
Mahajan K, Relhan V, Relhan AK, et al. Pityriasis rosea: an update on etiopathogenesis and management of difficult aspects. Indian Journal of Dermatology. 2016;61(4): 375–384. doi:10.4103/0019-5154.185699.
Mashoudy KD, Kim S, Farhadi L, et al. Beyond the herald patch: exploring the complex landscape of pityriasis rosea. American Journal of Clinical Dermatology. 2025;26(2): 237–250. doi:10.1007/s40257-024-00915-7.
Aydin Kurc M, Erfan G, Kaya AD, et al. Association between pityriasis rosea and HHV-6/HHV-7 infection: importance of sample selection and diagnostic techniques. Diagnostics. 2024;14(8): 843. doi:10.3390/diagnostics14080843.
Drago F, Ciccarese G, Javor S, et al. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. Journal of the European Academy of Dermatology and Venereology. 2016;30(3): 544–545. doi:10.1111/jdv.12942.
Drago F, Broccolo F, Ciccarese G. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Clinics in Dermatology. 2022;40(5): 586–590. doi: 10.1016/j.clindermatol.2022.01.002.
Al Mokadem S, Ghonemy S, Zidan A, et al. The role of interleukin-22 in pityriasis rosea. Clinical and Experimental Dermatology. 2017;42(1): 30–35. doi:10.1111/ced.12976.
Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. World Journal of Clinical Cases. 2017;5(6): 203–211. doi:10.12998/wjcc.v5.i6.203.
Shende AA, Chikhalkar SB. A cross-sectional study of epidemiological and clinical aspects of pityriasis rosea along with dermoscopic analysis and histopathology correlation. Indian Journal of Dermatology. 2024;69(2): 145–151. doi: 10.4103/ijd.ijd_1071_23.
Nwabudike LC. Does pityriasis rosea koebnerise? Our Dermatology Online. 2013;4(2): 189–190. doi:10.7241/ourd.20132.44.
Manduca S, Oh CS, Ong M, et al. The risks of pityriasis rosea in pregnancy: a review. International Journal of Women's Dermatology. 2025;11(1): e191. doi: 10.1097/JW9.0000000000000191.
